Experts explain why omega-3 products are well suited for tots.
Among the delights of this week’s GOED Exchange in Salt Lake City is a provocative, ongoing discussion about positioning omega-3 awareness towards children and the parents and caregivers who shop for them. While pregnant/nursing mothers and middle-aged adults have traditionally made up much of the consumer base for omega-3 products, experts at the GOED Exchange remind us that these essential fatty acids play a critical role in the developing brains and bodies of adolescents.
Bill Sears, MD, is a pediatrician. He also happens to be the author of dozens of parenting books, including such hits as The Healthy Pregnancy Book, The Baby Sleep Book, and You Can Go to the Potty. But his most recent endeavor, shared amongst this year’s GOED Exchange visitors, stars Dr. O. Mega III, the animated fish shown above, who teaches children about the simple healing powers of omega-3 fatty acids. With the help of the Children’s Miracle Network Hospitals, Sears plans to distribute copies of his new picture-filled pamphlet to thousands of children across 170 hospitals in North America. Dr. O will take those children on a fun adventure into the human arteries, a child’s brain, and even mommy’s womb-all places where his little fishy friends do their nutritional hard work.
A few more serious presentations provided Exchange attendees with the hard science behind omega-3 fatty acids-particularly DHA-and the developing brain. Aside from the stark images of brains with and without DHA deficiencies (there are many), it turns out there’s a considerable body of studies linking DHA deficiency with impaired brain development and greater risk for developing anxiety, depression, and other mental disorders. Furthermore, a number of recent trials link omega-3 supplementation with improvements in spelling, reading and behavior, and (with EPA) improvements in ADHD symptoms.
The story around omega-3 nutrition and young children will surely continue in the near and distant future.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.